- Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting
- Jacobio Pharma Announces 2023 Annual Results
- Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.
- Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor
Key statistics
On Tuesday, Jacobio Pharmaceuticals Group Co Ltd (1167:HKG) closed at 1.46, 5.80% above its 52-week low of 1.38, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.48 |
---|---|
High | 1.56 |
Low | 1.42 |
Bid | 1.46 |
Offer | 1.50 |
Previous close | 1.46 |
Average volume | 418.00k |
---|---|
Shares outstanding | 791.76m |
Free float | 442.77m |
P/E (TTM) | -- |
Market cap | 1.16bn HKD |
EPS (TTM) | -0.5025 HKD |
Data delayed at least 15 minutes, as of Apr 23 2024 09:09 BST.
More ▼